Your browser doesn't support javascript.
loading
Systemic anti-vascular endothelial growth factor therapies induce a painful sensory neuropathy.
Verheyen, An; Peeraer, Eve; Nuydens, Rony; Dhondt, Joke; Poesen, Koen; Pintelon, Isabel; Daniels, Anneleen; Timmermans, Jean-Pierre; Meert, Theo; Carmeliet, Peter; Lambrechts, Diether.
Affiliation
  • Verheyen A; Laboratory for Translational Genetics, Department of Oncology, University of Leuven, B-3000 Leuven, Belgium.
Brain ; 135(Pt 9): 2629-41, 2012 Sep.
Article in En | MEDLINE | ID: mdl-22734125

Full text: 1 Database: MEDLINE Main subject: Polyneuropathies / Vascular Endothelial Growth Factor Receptor-2 / Protein Kinase Inhibitors / Antibodies, Neutralizing / Ganglia, Spinal / Neuralgia Limits: Animals Language: En Journal: Brain Year: 2012 Type: Article Affiliation country: Belgium

Full text: 1 Database: MEDLINE Main subject: Polyneuropathies / Vascular Endothelial Growth Factor Receptor-2 / Protein Kinase Inhibitors / Antibodies, Neutralizing / Ganglia, Spinal / Neuralgia Limits: Animals Language: En Journal: Brain Year: 2012 Type: Article Affiliation country: Belgium